跳至主要内容
临床试验/CTRI/2025/12/099553
CTRI/2025/12/099553尚未招募不适用

Charting the Path to Elimination: Insights into Immune Responses to Measles, Mumps, and Rubella in an Adult South Indian Community Cohort

Stichting Blockchain for Impact Foundation1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2026年2月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
250
试验地点
1

研究概览

简要总结

This study aims to evaluate long-term immunity to measles, mumps, and rubella (MMR) among adults in South India, a population often overlooked in immunization programs. Despite India’s efforts toward measles and rubella elimination, significant immunity gaps remain, with declining antibody levels in adults and recurring mumps outbreaks. The study will measure binding and neutralizing antibodies, memory T-cell responses, and CD4+ T-cell help functions in adults aged between 18–40 years. Using advanced assays, including pseudovirus neutralization and T–B cell co-culture, the study will provide comprehensive insights into both humoral and cellular immunity. The findings will inform evidence-based recommendations for targeted booster doses, guide inclusion of mumps in the National Immunisation Programme, and strengthen outbreak preparedness. By addressing critical immunity gaps, this research directly supports India’s national priorities in infectious disease control and contributes to achieving measles and rubella elimination while enhancing protection against mumps.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Age 18–40 years, Residing in VHDSS zones 3 or 4, Providing informed consent.

排除标准

  • Immunosuppression for less than 6 months Chronic illness impacting immunity (e.g., HIV).

研究者

发起方
Stichting Blockchain for Impact Foundation
申办方类型
Other [A foundation registered under the laws of Netherlands.]
责任方
Principal Investigator
主要研究者

Dr Ramya Madhavan

Christian Medical College

研究点 (1)

Loading locations...

相似试验

Understanding Immunity to Measles, Mumps, and... | 临床试验